Senior insider sale
Chief Commercial Officer at ABEONA THERAPEUTICS INC. — senior position signals high conviction
$113.1K
17.51K shares
What this filing means
VASANTHAVADA MADHAV plans to sell 17.51K shares of ABEONA THERAPEUTICS INC. valued at approximately $113.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/29/2026ACC: 0001972481-26-000287
Officer· Chief Commercial Officer
Since Jan 2026
17.51K
Shares to sell
$113.1K
Approx. market value
9.70K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Awards
Equity Compensation
9/29/2026
9.70KTotal acquired9.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/29/2026 | Restricted Stock Awards Equity Compensation | 9.70K | — |
| Total | 9.70K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
12.61K
Market value
$87.8K
7/9/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.90K
Market value
$25.3K
9/29/2026
Total
Units
17.51K
Value
$113.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/9/2026 | 12.61K | $87.8K | — | Completed |
| Planned — Approximate Date | ||||
9/29/2026 | 4.90K | $25.3K | Nasdaq | Planned |
| Total | 17.51K | $113.1K | ||